Academia.eduAcademia.edu

Spyglass™ Spyscope Utility in Unusual Settings: A Case Series

2013, American Journal of Gastroenterology

Conclusion: high quality studies in support of endoscopic therapy in the management of PDiv are lacking. Available studies are mainly case series and of low quality. Based on currently available evidence, the estimated effi cacy of endoscopic therapy is 58% but this estimate is neither robust nor precision due to poor quality of available studies and signifi cant heterogeneity.

S32 Abstracts using a colonoscope for cannulating through the major papilla as well as evaluating the common bile duct and main pancreatic duct. Spyglass was also used to evaluate the minor papilla and the Santorini duct. To evaluate the clinical utility, efficacy, success rate and complications of using Spyglass in situations where either the anatomy was abnormal or minor papilla was evaluated. Methods: Six patients with suspected pancreatic pathology are included in the study. Two patients had previous surgeries. One patient had partial Billroth II gastrotectomy for gastric ulcers and two patients had a Whipple procedure in which an ordinary ERCP scope could not reach the area of interest, and therefore a colonoscope was utilized. These patients had pancreatic divisum, and the Spyglass was sequentially passed through the minor papilla. Results: Cannulation was successful in all patients using the colonoscope into the pancreatic duct. Both the first and second patients had Intraductal Papillary Mucinous Neoplasms (IPMN), and the second patient with Whipple had recurrent IPMN in the reminder of the pancreas. One of these patients had high grade dysplasia on Spyglass biopsies requiring a pancreatectomy. The third patient had pancreas divisum, a dilated pancreatic duct with a noted filling defect on ERCP, and abdominal pain. The Spyglass was passed through the minor papilla where the duct of Santorini was examined carefully. A stone was seen, but no tumor was identified. A balloon sweep of the pancreatic duct was performed, and the patient responded very well. The fourth patient had chronic pancreatitis with stricture of Wirsung, and a dilated Santorini duct. This patient was found to have incomplete divisum with chronic pancreatitis. Conclusion: Single-operator cholangiopancreatoscopy using a Spyglass probe through a colonoscope appears to be safe and effective procedure that can be performed in post-surgical anatomy and in patients with minor papilla pathology with dilated Santorini ducts. More studies with a larger patient population are required to evaluate the safety, efficacy and utility of Spyglass in such situations. [76A] Figure 1. 79 Conclusion: high quality studies in support of endoscopic therapy in the management of PDiv are lacking. Available studies are mainly case series and of low quality. Based on currently available evidence, the estimated efficacy of endoscopic therapy is 58% but this estimate is neither robust nor precision due to poor quality of available studies and significant heterogeneity. 77 Pancreatic Manifestations of Von Hippel Lindau: A Case Series Do SSRI/SNRI’s Increase the Risk of Post-sphinterotomy Bleeding in ERCP Patients? Prabhleen Chahal, Divya Yadav, John Vargo, MD, MPH. Cleveland Clinic, Cleveland, OH. Introduction: SSRI’s and SNRI’s have been variably reported to increase the risk of bleeding in patients undergoing interventional cardiovascular procedures. There is limited data showing increase risk of bleeding in patients on SNRIs undergoing percutaneous gastrostomy tube placement. We sought to assess the impact of SSRI/SNRI medication use on post-sphincterotomy bleeding. Methods: A cohort of all the patients who underwent ERCP with sphincterotomy at our facility from 2006-2014 were identified. Data pertaining to the patient demographics, technical aspects of the procedure, significant past medical including renal, cardiac, hepatic issues, coagulation disorder, bleeding Emmanuel Coronel, MD1, Mariano Gonzalez-Haba Ruiz, MD2, Sarah M. Nielsen, MS, CGC2, Uzma Siddiqui, MD1, Vani Konda, MD1, Irving Waxman, MD1, Andres Gelrud, MD3. 1. University of Chicago, Chicago, IL; 2. University of Chicago Medicine, Chicago, IL; 3. CERT, University of Chicago Medicine, Chicago, IL. Introduction: Von Hippel Lindau (VHL) syndrome is an autosomal dominant genetic disorder with a wide phenotypic expression. Few case reports describe the relationship between VHL and exocrine pancreatic insufficiency (EPI), and regulation of pancreatic endocrine function by the VHL gene has only been described in animals. However, close to 60 percent of patients show pancreatic involvement. Our aim is to corrrelate pancreatic findings with the presence of exocrine and/or endocrine function in a well genotyped and phenotyped group of patients with this disease. Methods: We performed a retrospective medical record review of patients with VHL in our Pancreatic Disease Center. We collected demographic data, genetic mutations, organ involvement, pancreatic imaging findings, degree of cyst involvement, clinical evidence of EPI, fecal elastase-1 (FE-1) and evidence of endocrine insufficiency (HbA1c). Results: We identified a total of 14 patients. Ten patients were women and four were men with a median age of 35 (19-70). Twelve had a documented genetic mutation, of which 11 had a strong family history of VHL. Four had lesions in the pancreas highly suggestive of pancreatic neuroendocrine tumors and one had a lesion suggestive of a serous cystadenoma. Simple pancreatic cystic lesions were present in nine patients. In this group, seven had complete cystic replacement of the pancreas (median age 48 (2370)), of which two had significant duodenal compression causing gastric outlet obstruction requiring laparoscopic gastrojejunostomy. Within the same group, three had symptoms suggestive of EPI and two had a FE-1 consistent with severe EPI (≤ 50 and 88 with normal being > 200 μg/g). One provided an inadequate sample. Pancreatic enzyme replacement therapy was initiated with improvement in symptoms including weight gain. Four patients with complete cystic replacement of the pancreas were screened for EPI, three had a normal FE-1 and one provided an inadequate sample. Among the three patients with symptomatic EPI, all had a HbA1c measured and two were newly diagnosed with type 3c diabetes (HbA1c 6.8 and 8.1). Conclusion: Complete cystic replacement of the pancreas is common in patients with VHL. Particular attention must be made for the early diagnosis of exocrine and endocrine pancreatic insufficiency, both of which were newly diagnosed in our cohort. Guidelines for screening and management of pancreatic involvement in patients with VHL are needed to improve and standardize quality of care. 78 Spyglass® Spyscope Utility in Unusual Settings: A Case Series Alyssa Kaleta1, Sagarika Sinha, DO2, Faizan Khan3, Laura Hamad, DO4, Hazem Tabbaa, DO5, Taylor Aldridge, MMS, PA-C6, Hafiz Muhammad Sharjeel Arshad, MD7, Kamran Ayub, MD8. 1. Advocate Lutheran General Hospital, Park Ridge, IL; 2. Franciscan St. James Health, Orland Park , IL; 3. Franciscan St. James hospital, Richton Park, IL; 4. Franciscan St. James Hospital, Darien, IL; 5. Franciscan St. James Health, Lemont, IL; 6. Southwest Gastroenterology, Minooka, IL; 7. University of Illinois at Chicago Advocate Christ Medical Center, Oak Lawn, IL; 8. Silver Cross Hospital, Oak Brook, IL. Introduction: Spyglass is a new technology for the direct visualization of the pancreatic duct and the common bile duct. Spyglass has been used for cannulating through the major papilla and looking into common bile duct and main pancreatic duct. We performed Spyglass in six patients in unusual settings The American Journal of GASTROENTEROLOGY [79A] Figure 1. VOLUME 110 | SUPPLEMENT 1 | OCTOBER 2015 www.amjgastro.com